Blau Farmacêutica Future Growth

Future criteria checks 4/6

Blau Farmacêutica is forecasted to grow earnings and revenue by 16.8% and 18.4% per annum respectively. EPS is expected to grow by 15%. Return on equity is forecast to be 20.8% in 3 years.

Key information

16.8%

Earnings growth rate

15.0%

EPS growth rate

Biotechs earnings growth19.9%
Revenue growth rate18.4%
Future return on equity20.8%
Analyst coverage

Good

Last updated11 May 2023

Recent future growth updates

Recent updates

What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

May 14
What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates

Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Feb 24
Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Oct 14
Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely

Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Aug 17
Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)

Earnings and Revenue Growth Forecasts

BOVESPA:BLAU3 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,372581N/AN/A6
12/31/20242,079474654336
12/31/20231,601382-74563
3/31/20201,008203103217N/A
12/31/2019978200125221N/A
9/30/201998718672131N/A
6/30/20199381772482N/A
3/31/20198191291977N/A
12/31/20187821233283N/A
9/30/2018677902767N/A
6/30/2018616786290N/A
3/31/2018634110104137N/A
12/31/201761810390127N/A
12/31/201643132N/A46N/A
12/31/201537922N/A42N/A
12/31/201429917N/A14N/A
12/31/201327115N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BLAU3's forecast earnings growth (16.8% per year) is above the savings rate (9.7%).

Earnings vs Market: BLAU3's earnings (16.8% per year) are forecast to grow faster than the BR market (11.6% per year).

High Growth Earnings: BLAU3's earnings are forecast to grow, but not significantly.

Revenue vs Market: BLAU3's revenue (18.4% per year) is forecast to grow faster than the BR market (6.1% per year).

High Growth Revenue: BLAU3's revenue (18.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: BLAU3's Return on Equity is forecast to be high in 3 years time (20.8%)


Discover growth companies